COMMUNIQUÉS West-GlobeNewswire

Yerbae Expands Colorado Distribution Through Eagle Rock Distributing and King Soopers, Seeking to Mirror Safety Shot’s Success in Major Supermarket Chains

04/02/2025 - 16:46

SCOTTSDALE, Ariz., Feb. 04, 2025 (GLOBE NEWSWIRE) -- Yerbaé Brands Corp. (TSX-V: YERB.U; OTCQX: YERBF) (“Yerbaé” or the “Company”), a plant-based functional beverage company, today announced a new distribution agreement [...]

NeuroOne® Regains Compliance with Nasdaq Listing Requirements

04/02/2025 - 16:56

EDEN PRAIRIE, Minn., Feb. 04, 2025 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and [...]

Soda Health Achieves HITRUST e1 Certification Demonstrating Foundational Cybersecurity

04/02/2025 - 17:00

HITRUST e1 Certification validates Soda Health is committed to foundational cybersecurity controls and information risk management. CHICAGO, Feb. 04, 2025 (GLOBE NEWSWIRE) -- Soda Health a leading provider of Smart [...]

FDA approves Roche’s Susvimo as the first and only continuous delivery treatment for the leading cause of diabetes-related blindness

04/02/2025 - 17:45

Susvimo is the first and only continuous delivery treatment that offers an alternative to regular eye injections to treat diabetic macular edema (DME) With as few as two treatments per year, Susvimo may help people with [...]

Informations relatives au nombre total de droits de vote et d’actions composant le capital

04/02/2025 - 18:00

Informations relatives au nombre total de droits de vote et d’actions composant le capital Nantes, le 4 février 2025 – En application de l’article L. 233-8 II du Code de commerce et de l’article 223-16 du Règlement [...]

Glucotrack, Inc. Announces Pricing of $3.0 Million Public Offering

04/02/2025 - 18:24

Rutherford, NJ., Feb. 04, 2025 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (Nasdaq: GCTK), a medical technology company focused on the design, development, and commercialization of novel technologies for people with diabetes, [...]

Jushi Announces Support of Adult-Use Cannabis in Pennsylvania Governor’s Annual Budget Proposal and Address

04/02/2025 - 19:00

BOCA RATON, Fla., Feb. 04, 2025 (GLOBE NEWSWIRE) -- Jushi Holdings Inc. (“Jushi” or the “Company”) (CSE: JUSH ) ( OTCQX: JUSHF ), a vertically integrated, multi-state cannabis operator, made the following statement [...]

LiveCare Inc. Announces Resolution of Investigation with the U.S. Department of Justice After Proactive Self-Disclosure

04/02/2025 - 20:30

Venice, Florida, Feb. 04, 2025 (GLOBE NEWSWIRE) -- LiveCare Inc. (OTCMKTS: LVCE), today announced the resolution of an investigation by the U.S. Department of Justice of allegations related to the Anti-Kickback Statute [...]

Revium Rx (RVRC) Completes Acquisition of LipoVation Ltd.

04/02/2025 - 20:31

Revium Rx Shifts Focus with Acquisition of LipoVation Ltd., Advancing Nanoparticle-Based Drug Development Israel, Feb. 04, 2025 (GLOBE NEWSWIRE) -- February 4, 2025 – Revium Rx (formerly Revium Recovery Inc., OTC: RVRC [...]

Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

04/02/2025 - 22:00

SOUTH SAN FRANCISCO, Calif., Feb. 04, 2025 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that on January 31, 2025 it granted stock options to purchase an aggregate of 64,587 shares of [...]

Intellia Therapeutics Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

04/02/2025 - 22:01

CAMBRIDGE, Mass., Feb. 04, 2025 (GLOBE NEWSWIRE) -- Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading clinical-stage gene editing company focused on revolutionizing medicine with CRISPR-based therapies, today [...]

Fate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

04/02/2025 - 22:01

SAN DIEGO, Feb. 04, 2025 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc. (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to bringing a first-in-class pipeline of induced pluripotent stem cell (iPSC)- [...]

Nuvectis Pharma Announces Proposed Public Offering of Common Stock

04/02/2025 - 22:05

FORT LEE, NJ, Feb. 04, 2025 (GLOBE NEWSWIRE) -- Nuvectis Pharma, Inc. (Nasdaq: NVCT), a clinical-stage biopharmaceutical company focused on the development of innovative precision medicines for the treatment of serious [...]

Exagen Inc. to Participate in Upcoming Investor Conferences

04/02/2025 - 22:05

CARLSBAD, Calif., Feb. 04, 2025 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing, today announced that management will participate in the following upcoming investor conferences: [...]

Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

04/02/2025 - 22:05

CAMBRIDGE, Mass., Feb. 04, 2025 (GLOBE NEWSWIRE) -- Akebia Therapeutics ® , Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, granted seven newly [...]

InnovAge Announces Financial Results For the Fiscal Second Quarter Ended December 31, 2024

04/02/2025 - 22:05

DENVER, Feb. 04, 2025 (GLOBE NEWSWIRE) -- InnovAge Holding Corp. (“InnovAge” or the “Company”) (Nasdaq: INNV), an industry leader in providing comprehensive healthcare programs to frail, predominantly dual-eligible [...]

Apellis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

04/02/2025 - 22:05

WALTHAM, Mass., Feb. 04, 2025 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals , Inc. (Nasdaq: APLS) announced today that the company approved the grant of equity awards to three new employees with a grant date of February 3 [...]

CVRx Reports Fourth Quarter and Full Year 2024 Financial and Operating Results

04/02/2025 - 22:05

MINNEAPOLIS, Feb. 04, 2025 (GLOBE NEWSWIRE) -- CVRx, Inc. ("CVRx"), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative neuromodulation solutions for patients [...]

Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

04/02/2025 - 22:30

SAN FRANCISCO, Feb. 04, 2025 (GLOBE NEWSWIRE) -- Olema Pharmaceuticals, Inc. (“Olema” or “Olema Oncology”, Nasdaq: OLMA), a clinical-stage biopharmaceutical company focused on the discovery, development, and [...]